Annual Revenue
$145.24 M
+$35.78 M+32.69%
December 31, 2023
Summary
- As of February 7, 2025, TVTX annual revenue is $145.24 million, with the most recent change of +$35.78 million (+32.69%) on December 31, 2023.
- During the last 3 years, TVTX annual revenue has fallen by -$53.08 million (-26.77%).
- TVTX annual revenue is now -26.77% below its all-time high of $198.32 million, reached on December 31, 2020.
Performance
TVTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$62.90 M
+$8.78 M+16.23%
September 30, 2024
Summary
- As of February 7, 2025, TVTX quarterly revenue is $62.90 million, with the most recent change of +$8.78 million (+16.23%) on September 30, 2024.
- Over the past year, TVTX quarterly revenue has increased by +$17.84 million (+39.59%).
- TVTX quarterly revenue is now -7.80% below its all-time high of $68.22 million, reached on September 30, 2021.
Performance
TVTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$203.45 M
+$25.80 M+14.53%
September 30, 2024
Summary
- As of February 7, 2025, TVTX TTM revenue is $203.45 million, with the most recent change of +$25.80 million (+14.53%) on September 30, 2024.
- Over the past year, TVTX TTM revenue has increased by +$58.21 million (+40.08%).
- TVTX TTM revenue is now -8.04% below its all-time high of $221.22 million, reached on September 30, 2021.
Performance
TVTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TVTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.7% | +39.6% | +40.1% |
| 3 y3 years | -26.8% | +114.4% | +27.1% |
| 5 y5 years | -11.6% | +114.4% | +27.1% |
TVTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.7% | at high | +263.8% | at high | +120.4% |
| 5 y | 5-year | -26.8% | +32.7% | -7.8% | +263.8% | -8.0% | +120.4% |
| alltime | all time | -26.8% | +415.0% | -7.8% | +263.8% | -8.0% | >+9999.0% |
Travere Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $62.90 M(+16.2%) | $203.45 M(+14.5%) |
| Jun 2024 | - | $54.12 M(+30.8%) | $177.64 M(+14.1%) |
| Mar 2024 | - | $41.37 M(-8.2%) | $155.72 M(+7.2%) |
| Dec 2023 | $145.24 M(+32.7%) | $45.06 M(+21.5%) | $145.24 M(+12.1%) |
| Sep 2023 | - | $37.09 M(+15.2%) | $129.52 M(+7.5%) |
| Jun 2023 | - | $32.20 M(+4.2%) | $120.50 M(-15.4%) |
| Mar 2023 | - | $30.89 M(+5.3%) | $142.47 M(-11.0%) |
| Dec 2022 | $109.46 M(-17.0%) | $29.34 M(+4.5%) | $160.07 M(+73.4%) |
| Sep 2022 | - | $28.07 M(-48.2%) | $92.32 M(-30.3%) |
| Jun 2022 | - | $54.17 M(+11.7%) | $132.47 M(-0.3%) |
| Mar 2022 | - | $48.49 M(-226.3%) | $132.92 M(+0.8%) |
| Dec 2021 | $131.84 M(-33.5%) | -$38.41 M(-156.3%) | $131.84 M(-40.4%) |
| Sep 2021 | - | $68.22 M(+24.9%) | $221.22 M(+8.4%) |
| Jun 2021 | - | $54.62 M(+15.2%) | $204.15 M(+3.1%) |
| Mar 2021 | - | $47.41 M(-7.0%) | $197.96 M(-0.2%) |
| Dec 2020 | $198.32 M(+13.1%) | $50.98 M(-0.3%) | $198.32 M(+2.2%) |
| Sep 2020 | - | $51.14 M(+5.6%) | $194.03 M(+3.6%) |
| Jun 2020 | - | $48.43 M(+1.4%) | $187.26 M(+2.0%) |
| Mar 2020 | - | $47.77 M(+2.3%) | $183.54 M(+4.7%) |
| Dec 2019 | $175.34 M | $46.69 M(+5.2%) | $175.34 M(+1.7%) |
| Sep 2019 | - | $44.37 M(-0.7%) | $172.42 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $44.71 M(+13.0%) | $168.75 M(+2.0%) |
| Mar 2019 | - | $39.57 M(-9.6%) | $165.38 M(+0.7%) |
| Dec 2018 | $164.25 M(+6.0%) | $43.77 M(+7.5%) | $164.25 M(+1.0%) |
| Sep 2018 | - | $40.71 M(-1.5%) | $162.65 M(+0.2%) |
| Jun 2018 | - | $41.34 M(+7.6%) | $162.29 M(+1.6%) |
| Mar 2018 | - | $38.43 M(-8.9%) | $159.75 M(+3.1%) |
| Dec 2017 | $154.94 M(+16.0%) | $42.18 M(+4.6%) | $154.94 M(+3.2%) |
| Sep 2017 | - | $40.34 M(+4.0%) | $150.09 M(+4.5%) |
| Jun 2017 | - | $38.80 M(+15.4%) | $143.69 M(+4.0%) |
| Mar 2017 | - | $33.62 M(-9.9%) | $138.20 M(+3.5%) |
| Dec 2016 | $133.59 M(+33.7%) | $37.33 M(+10.0%) | $133.59 M(+5.4%) |
| Sep 2016 | - | $33.95 M(+1.9%) | $126.71 M(+4.9%) |
| Jun 2016 | - | $33.31 M(+14.8%) | $120.77 M(+8.3%) |
| Mar 2016 | - | $29.01 M(-4.7%) | $111.53 M(+11.6%) |
| Dec 2015 | $99.89 M(+254.2%) | $30.45 M(+8.7%) | $99.89 M(+19.6%) |
| Sep 2015 | - | $28.00 M(+16.4%) | $83.53 M(+30.8%) |
| Jun 2015 | - | $24.07 M(+38.5%) | $63.87 M(+40.2%) |
| Mar 2015 | - | $17.37 M(+23.3%) | $45.55 M(+61.5%) |
| Dec 2014 | $28.20 M | $14.09 M(+68.7%) | $28.20 M(+99.8%) |
| Sep 2014 | - | $8.35 M(+45.4%) | $14.12 M(+144.7%) |
| Jun 2014 | - | $5.74 M(>+9900.0%) | $5.77 M(>+9900.0%) |
| Mar 2014 | - | $27.90 K | $27.90 K |
FAQ
- What is Travere Therapeutics annual revenue?
- What is the all time high annual revenue for Travere Therapeutics?
- What is Travere Therapeutics annual revenue year-on-year change?
- What is Travere Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Travere Therapeutics?
- What is Travere Therapeutics quarterly revenue year-on-year change?
- What is Travere Therapeutics TTM revenue?
- What is the all time high TTM revenue for Travere Therapeutics?
- What is Travere Therapeutics TTM revenue year-on-year change?
What is Travere Therapeutics annual revenue?
The current annual revenue of TVTX is $145.24 M
What is the all time high annual revenue for Travere Therapeutics?
Travere Therapeutics all-time high annual revenue is $198.32 M
What is Travere Therapeutics annual revenue year-on-year change?
Over the past year, TVTX annual revenue has changed by +$35.78 M (+32.69%)
What is Travere Therapeutics quarterly revenue?
The current quarterly revenue of TVTX is $62.90 M
What is the all time high quarterly revenue for Travere Therapeutics?
Travere Therapeutics all-time high quarterly revenue is $68.22 M
What is Travere Therapeutics quarterly revenue year-on-year change?
Over the past year, TVTX quarterly revenue has changed by +$17.84 M (+39.59%)
What is Travere Therapeutics TTM revenue?
The current TTM revenue of TVTX is $203.45 M
What is the all time high TTM revenue for Travere Therapeutics?
Travere Therapeutics all-time high TTM revenue is $221.22 M
What is Travere Therapeutics TTM revenue year-on-year change?
Over the past year, TVTX TTM revenue has changed by +$58.21 M (+40.08%)